| GLS1-mediated glutaminolysis unbridled by MALT1 protease promotes psoriasis pathogenesis X Xia, G Cao, G Sun, L Zhu, Y Tian, Y Song, C Guo, X Wang, J Zhong, ... The Journal of clinical investigation 130 (10), 5180-5196, 2020 | 65 | 2020 |
| Glutaminolysis mediated by MALT1 protease activity facilitates PD-L1 expression on ABC-DLBCL cells and contributes to their immune evasion X Xia, W Zhou, C Guo, Z Fu, L Zhu, P Li, Y Xu, L Zheng, H Zhang, C Shan, ... Frontiers in Oncology 8, 632, 2018 | 27 | 2018 |
| 1α, 25 (OH) 2D3 reverses exhaustion and enhances antitumor immunity of human cytotoxic T cells P Li, X Zhu, G Cao, R Wu, K Li, W Yuan, B Chen, G Sun, X Xia, H Zhang, ... Journal for immunotherapy of cancer 10 (3), 2022 | 24 | 2022 |
| IDO inhibition facilitates antitumor immunity of Vγ9Vδ2 T cells in triple-negative breast cancer P Li, R Wu, K Li, W Yuan, C Zeng, Y Zhang, X Wang, X Zhu, J Zhou, P Li, ... Frontiers in Oncology 11, 679517, 2021 | 20 | 2021 |
| Microbial metabolite butyrate promotes anti-PD-1 antitumor efficacy by modulating T cell receptor signaling of cytotoxic CD8 T cell X Zhu, K Li, G Liu, R Wu, Y Zhang, S Wang, M Xu, L Lu, P Li Gut Microbes 15 (2), 2249143, 2023 | 11 | 2023 |
| Androgens in patients with luminal B and HER2 breast cancer might be a biomarker promoting anti-PD-1 efficacy P Li, W Yuan, R Wu, C Zeng, K Li, L Lu Frontiers in Oncology 12, 917400, 2022 | 5 | 2022 |
| Inhibition of MALT1 paracaspase activity improves lesion recovery following spinal cord injury H Zhang, G Sun, X Li, Z Fu, C Guo, G Cao, B Wang, Q Wang, S Yang, D Li, ... Science Bulletin 64 (16), 1179-1194, 2019 | 5 | 2019 |
| 1α, 25 (OH) 2D3 ameliorates insulin resistance by alleviating γδ T cell inflammation via enhancing fructose-1, 6-bisphosphatase 1 expression P Li, K Li, W Yuan, Y Xu, P Li, R Wu, J Han, Z Yin, L Lu, Y Gao Theranostics 13 (15), 5290, 2023 | 2 | 2023 |
| Serum vitamin D deficiency is associated with increased risk of γδ T cell exhaustion in HBV‐infected patients K Li, E Lu, Q Wang, R Xu, W Yuan, R Wu, L Lu, P Li Immunology 171 (1), 31-44, 2024 | | 2024 |
